Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABCL | AZN | AMGN | GILD | BMY |
| Company | Abcellera Biologics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 3.37 | 190.33 | 368.27 | 143.50 | 59.92 |
| High | 3.56 | 195.79 | 378.82 | 146.92 | 60.64 |
| Low | 3.35 | 189.35 | 366.53 | 143.49 | 59.25 |
| Latest | 3.52 | 194.95 | 376.97 | 146.63 | 60.63 |
| Change | +0.07 | +0.73 | +7.44 | +2.70 | +0.34 |
| % Change | +2.03% | +0.38% | +2.01% | +1.88% | +0.56% |
| Volume | 1,948,699 | 1,874,944 | 2,697,722 | 5,185,972 | 10,556,003 |
| 20-Day Average Volume | 3,696,365 | 2,266,963 | 2,646,291 | 7,373,446 | 12,786,091 |
| Previous Close | 3.45 | 194.22 | 369.53 | 143.93 | 60.29 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.32 | 202.53 | 375.78 | 149.56 | 60.92 |
| 20-Day Raw Stochastic | 65.75% | 30.72% | 51.44% | 26.58% | 37.88% |
| 20-Day Relative Strength | 49.73 | 48.87 | 56.84 | 54.59 | 56.98 |
| Weighted Alpha | +16.71 | +31.11 | +28.77 | +38.44 | +15.56 |
| Today's Opinion | 80% Sell | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 80% Sell | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.72% since 03/02/26 | -4.31% since 03/02/26 | -2.36% since 03/02/26 | -2.27% since 03/02/26 | -2.77% since 03/02/26 |
| Low | 3.35 on 03/09/26 | 189.45 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 59.25 on 03/09/26 |
| High | 3.79 on 03/03/26 | 203.29 on 03/04/26 | 381.74 on 03/03/26 | 148.92 on 03/04/26 | 62.58 on 03/04/26 |
| 1-Month | |||||
| %Chg | +9.47% since 02/09/26 | +3.69% since 02/09/26 | +0.20% since 02/09/26 | -3.33% since 02/09/26 | -0.26% since 02/09/26 |
| Low | 2.93 on 02/12/26 | 189.45 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 59.23 on 02/19/26 |
| High | 3.84 on 03/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -4.21% since 12/09/25 | +8.52% since 12/09/25 | +19.99% since 12/09/25 | +22.85% since 12/09/25 | +19.67% since 12/09/25 |
| Low | 2.74 on 02/05/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 4.85 on 01/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -16.86% since 09/09/25 | +20.01% since 09/09/25 | +34.51% since 09/09/25 | +26.67% since 09/09/25 | +28.34% since 09/09/25 |
| Low | 2.74 on 02/05/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 6.51 on 10/08/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,045,902 | 301,217,344 | 199,201,792 | 178,677,728 | 122,779,024 |
| Shares Outstanding, K | 303,160 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 75,130,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -146,410,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 44,850,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -8,950,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.84 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 11/06/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/14/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.56 | 16.82 | 17.81 | 9.88 |